Thursday, June 11, 2026
Google search engine
Home Blog Page 477

MONEYME launches ‘Kick your goals’ campaign with Seven Network and AFL legend Luke Hodge

admin
-
0
MONEYME launches ‘Kick your goals’ campaign with Seven Network and AFL legend Luke Hodge

SYDNEY, March 8, 2024 /PRNewswire/ — Digital lender and non-bank challenger MONEYME (ASX: MME) has launched an above-the-line advertising campaign in partnership with the Seven Network, featuring TV commercials with respected AFL legend Luke Hodge.

(L-R) Richard Bray, Luke Hodge, James Falzon
(L-R) Richard Bray, Luke Hodge, James Falzon

The ‘Kick your goals’ campaign will set MONEYME up for increased brand awareness and consideration as the lender prepares for growth after a strong first half result and at a time when the economic outlook is improving.  

The campaign will see MONEYME featured throughout the AFL 2024 season and leverages significant prepaid media spend that was banked when MONEYME acquired SocietyOne in March 2022.

The campaign was developed in collaboration with the Seven Network’s in-house marketing solutions team 7RED and their creative team Red Engine and showcases how Australians can achieve their goals and aspirations faster with MONEYME’s online personal loans.

Luke Hodge, or “Hodgey” for short, is a former Australian rules footballer and will be part of Seven’s commentary team for the 2024 AFL season.

Hodgey played for the Hawthorn Football Club and the Brisbane Lions and is a four-time premiership player, three-time premiership captain, and a two-time Norm Smith Medallist. He is regarded as one of the most respected players, particularly as a captain, to have ever participated in the sport.

For the first time in AFL history, the Toyota AFL Premiership season will kick off with an ‘Opening Round’ comprising four matches in Queensland and New South Wales, which is when the campaign will make its debut, a week before the traditional ‘Round One’.

As part of the campaign execution, a series of captivating TV commercials will feature Hodgey exploring the common goals and aspirations of everyday Aussies, allowing viewers to witness relatable stories that reflect the diverse dreams of people across the country.

The campaign aims to inspire individuals to take the first step towards realising their aspirations and reinforces MONEYME’s commitment to supporting Australians on their financial journeys, according to MONEYME CEO, Clayton Howes.

Clayton Howes, CEO of MONEYME, said: “At MONEYME, we believe in empowering individuals to go after their ambitions, and the ‘Kick your goals’ campaign aims to demonstrate how our personal loans can accelerate their journey towards achieving their goals.

“We’re thrilled to kick off our partnership with the Seven Network to build the MONEYME brand this AFL season. This campaign by 7RED and Red Engine aligns perfectly with our positive perspective on the economic outlook as we pursue growth, and it’s a well-timed opportunity to use the prepaid media buy from our acquisition of SocietyOne.” 

Richard Bray, Chief Marketing and Sales Officer of MONEYME, said: “The ‘Kick your goals’ campaign emphasises the similarities between AFL players and Australians who strive to achieve their goals. Just like AFL players need a team behind them to succeed, sometimes regular Aussies need a little help to kick their own goals faster. That’s exactly what a MONEYME personal loan can provide – that financial help to accelerate their journey.”

In the Opening Round, Sydney will host Melbourne at the SCG starting on Thursday March 7th, followed by Brisbane versus Carlton at the Gabba on Friday night, March 8th. Gold Coast will then host Richmond at Heritage Bank Stadium on Saturday afternoon, March 10th, before Greater Western Sydney takes on reigning premiers Collingwood at GIANTS Stadium on Saturday night.

For more information about MONEYME and its ‘Kick your goals’ campaign, visit www.moneyme.com.au or follow MONEYME on social media. 

Credits

Red Engine
Head of Creative and Operations: James Falzon
Creative Manager: Benjamin Fletcher
Creative/ Director/ Editor: Samantha Power
Producer: Chris Seeto
DOP: Emilio Abbonozio
Production Designer: Madison Mullane
Stills Photographer: Natalie Alder
Socials: Rudge Hollis, Steve Watson, Josh Kind

7RED
Joint Ventures Business Manager: Ben Jones
Senior Campaign Manager: Amanda Soliman

MONEYME
CEO: Clayton Howes
Chief Marketing and Sales Officer: Richard Bray
Head of Marketing: Bryce Griffith
Head of Design: Gloria Torres
Brand and Communications Manager: Cecilia Bonnevier
Motion Graphic Designer: Marvyn Mendoza

About MONEYME

MONEYME is a founder-led digital lender and Certified B Corporation™.  We challenge the traditional ways of credit and simplify the borrowing experience with digital-first experiences that meet the needs of modern consumers.

We target customers with higher-than-average credit profiles through a range of fast, flexible, and competitively priced products, including car loans, personal loans, and credit cards.

Our point of difference is delivering unrivalled customer experiences powered by smart technology. From near real-time credit decisioning to loans that settle in minutes, we deliver speed and efficiency in everything we do.

We service ‘Generation Now’, ambitious Australians who expect more from life and the companies they engage with. We uphold a strong ethos of sustainability and hold ourselves accountable to the high standards of the B Corp movement.

MONEYME Limited is listed on the ASX, and the Group includes licensed and regulated credit and financial services providers operating in Australia.

For more information, visit moneyme.com.au or investors.moneyme.com.au 

Source

This La Scala-inspired chopped salad has gone viral. Here’s why — and how to make it.

admin
-
0
This La Scala-inspired chopped salad has gone viral. Here’s why — and how to make it.

It’s not every day that something as benign as a salad goes viral, but here we are. The La Scala salad, which is essentially an Italian chopped salad made of lettuce, salami, mozzarella and garbanzo beans (aka chickpeas), is all over social media, with nutritionists and foodies sharing how to make the easy dish. While this type of salad is more popular than ever — Google Trends recently reported that searches for “chopped salad” are at an all-time high — it’s been around for decades. The La Scala chopped salad reportedly originates from a Beverly Hills restaurant of the same name that introduced it in the 1950s (and it’s still on the restaurant’s menu), while some attribute the salad’s more recent surge in popularity to the Kardashians and other celebrities being fans of the tasty meal.

So what is it about this salad that has some people salivating? And how do you make it? Here’s what you need to know.

Why is this chopped salad popular?

“As with many things in today’s world, we can thank a celebrity and social media, in this case, the Kardashians, for this salad’s popularity,” Keri Gans, a registered dietitian, nutritionist and author of The Small Change Diet, tells Yahoo Life. But beyond the celebrity factor, Gans says that when a salad is chopped and tossed, “it combines all the ingredients, adding more flavor to each forkful.”

Julie Pace, founder and dietitian at Core Nutrition + Wellness, agrees, telling Yahoo Life: “Chopped salads have become popular because they’re versatile, colorful and so easy to prepare. With fresh ingredients chopped into bite-sized pieces, they’re visually appealing and a convenient way to enjoy a variety of flavors and textures in each bite.”

In making a delicious salad, Pace says that dressing plays “a significant role” but notes that “various textures and flavors, such as crunchy nuts, crisp veggies, creamy avocado or tangy cheese can elevate the salad’s taste profile. Overall, the dressing should complement and enhance the flavors of the salad ingredients without overpowering them.”

Is it healthy?

Overall, the La Scala salad includes lots of healthy ingredients such as chickpeas, lettuce and olive oil, says Gans. Vanessa Rissetto, registered dietitian and chief executive officer of Culina Health, calls out the salad’s high-fiber chickpeas in particular, adding that they’re also a “good source of protein.”

However, Gans notes that the salad “may also skew on the high sodium side because of salami. As far as cheeses go, mozzarella is lower in saturated fat and sodium than many options. If an individual is on a low-sodium diet they may want to only enjoy this salad on occasion.”

Pace says opting for minimally processed ingredients and choosing dressings low in saturated fat, such as vinaigrettes, can contribute to a healthier option.

What are some misperceptions people have about salads?

Salads aren’t just a side dish — they can be a meal in themselves. The key, say all three experts, is making sure salads have enough protein so you’re not left hungry an hour after eating them. Pace says that salads can be a satisfying meal “when they include adequate protein and fiber to promote fullness. Incorporating sources of healthy fats like avocado, nuts and seeds can also contribute to satiety.”

The mistake that some make when putting together salads, says Rissetto, is when “people just put iceberg lettuce and lots of dressing, but forget things like protein for fullness and maybe some cheese for flavor. Nuts and seeds for omegas. There’s a lot more than just a dry piece of chicken to make your salad amazing — you just have to get creative!” Besides grilled chicken, Gans says that good sources of protein include salmon, legumes or shrimp.

Gans also notes that salads are not necessarily low in calories and in some instances, “it can be rather high,” adding: “One should be careful of the amount of salad dressing used, especially if it contains olive oil or other fats, as the calories could add up quickly.”

But overall, Gans says that “a salad is an opportunity to get many nutritious foods into your diet at one meal.”

What’s the recipe?

If you’d like to try making this chopped salad at home, you can find lots of recipes online. Here’s a recipe by chef and Big Bites cookbook author Kathleen Ashmore, who describes it as “like an Italian sub in salad form.”

Salad ingredients:

  • 1 head iceberg lettuce, rinsed and finely chopped

  • 1 ⁄4 lb. Italian salami, julienned

  • 1 cup shredded mozzarella cheese

  • 1 15 1/2 ounce can garbanzo beans, rinsed and well-drained

Dressing ingredients:

  • ⅓ cup extra-virgin olive oil

  • 1/4 cup red wine vinegar

  • 2 tsp. Dijon mustard

  • 1/2 tsp. each salt and pepper

  • 1/4 cup grated pecorino romano OR parmesan cheese, plus more for serving

Instructions:

  1. To make vinaigrette: In a large serving bowl, combine oil, vinegar, mustard, and salt and pepper to taste; whisk until well blended.

  2. To the bowl, combine lettuce, salami, mozzarella and garbanzo beans. Toss with vinaigrette to coat well.

  3. Finish with more pecorino and salt and black pepper, if desired.

Source

UOB data reveals women are powering spending with their rising affluence over last five years

admin
-
0
UOB data reveals women are powering spending with their rising affluence over last five years

The Bank continues to meet women’s evolving needs and lifestyles with pioneering UOB Lady’s Card and Lady’s Savings Account

SINGAPORE, March 8, 2024 /PRNewswire/ — In line with International Women’s Day and to celebrate 35 years of Southeast Asia’s longest-running women-centric card, the UOB Lady’s Card in Singapore, UOB reveals data pointing to the growing economic power of women.

From 2019 to 2023, total card billings for the UOB Lady’s Debit and Credit Card in Singapore rose by about 70 per cent, while the total number of transactions conducted more than doubled within the same period. Average active spending per Lady’s Credit Card also rose by more than 50 per cent in the last five years.

Ms Jacquelyn Tan, Head of Group Personal Financial Services at UOB, said, “We celebrate women’s individuality and how they want to live, work and play. Our data shows that women today are becoming more financially independent, working towards their aspirational life goals like pursuing lifestyle experiences and building savings for the future. We leverage these useful insights to continually enhance our products and offerings for ladies. The UOB Lady’s Card and Lady’s Savings Account are a symbol of innovation and evolution. We work with a wide range of partners to curate the best rewards for our female customers, catering to their different lifestyles and life stages.”

Women seeking greater lifestyle and entertainment experiences

UOB has given women the empowerment of choice for their expenses. The UOB Lady’s Credit Card’s pioneering rewards category(ies) feature was introduced in 2019, allowing cardholders to select up to two preferred rewards category(ies) to earn rewards through transactions that best resonate with their lifestyles. Cardholders also have the flexibility to switch up their preferred rewards category(ies) every quarter. This innovative feature empowers women to take control of their rewards, earning higher returns and entitlements for their preferences even as their lifestyles and interests evolve.

From 2019 to 2022, “dining” and “fashion” consistently emerged as the top two enrolled preferred rewards category(ies). With the comeback of post-Covid travel, “travel” overtook “fashion” as the second highest enrolled category in 2023, after “dining”.

Based on Singapore credit card transactions, dining saw the steepest growth, increasing by about 150 per cent from 2019 to 2023. This was followed by entertainment-related spending[1], which grew by more than 90 per cent in the last five years. This is driven largely by its growth post-Covid, which saw a 175 per cent and over 140 per cent growth year on year in 2022 and 2023 respectively. Travel-related spending saw a similar spike in the last few years, growing by close to 300 per cent and over 160 per cent year on year from 2021 to 2022 and 2022 to 2023 respectively. Meanwhile, fashion-related spending[2] grew by close to 30 per cent.

Part of the growing popularity of lifestyle experiences can be attributed to the uptick in entertainment-related activities in the region, such as the ongoing Taylor Swift The Eras Tour in Singapore, alongside consumers’ burgeoning interest in this space. New female UOB cardholders in Singapore increased by almost 10 per cent in June last year in the week following the announcement of the global artiste’s concert. Close to 65 per cent of Singapore customers purchasing tickets during the 5 July presale and 7 July general sale were females.

Growing affluence of women consumers

Beyond their growing purse strings, women are also gaining financial affluence. Female customers’ total assets under management with UOB have increased steadily over the years, growing by close to 35 per cent from end-2020 to end-2023.

The growing pool of women qualifying for higher tiers of the UOB Lady’s Card also demonstrates the growth in women’s wealth and disposable income over the years. In Singapore, the number of approved UOB Lady’s Solitaire Cards[3], the upgraded tier of the UOB Lady’s Card, surged by over 250 per cent from 2019 to 2023. New acquisitions for the Bank’s by-invite-only limited edition UOB Lady’s Solitaire Metal Card, the first contactless World Elite Mastercard Metal Card in Southeast Asia, also more than doubled year on year.

Women are saving up more for rainy days

At the same time, women are also preparing to tackle the rising costs of living by futureproofing their finances. According to UOB’s ASEAN Consumer Sentiment Study 2023[4], more than 70 per cent of women in Singapore expressed concern over rising inflation, while more than 60 per cent were worried about their long-term financial commitments.

To combat this, women consumers are making efforts to accumulate more savings. As of December 2023, over 60 per cent of UOB’s Fixed Deposit accounts are opened by female customers. Average savings account balances owned by ladies also grew by 6 per cent year on year in 2023. Consumers are also maximising their savings and protection needs with UOB’s suite of products – the number UOB Lady’s Savings Account holders grew by more than 30 per cent year on year, while close to half of all UOB’s female customers in Singapore hold a high-yield savings account, such as the UOB One or Stash Account.

UOB empowers women to achieve both short- and long-term goals

As women today grow in their financial muscle, UOB believes in empowering them to take control of their money, to enjoy what they love without compromising on their future goals.

The UOB Lady’s Card launched in 1989 as the first-ever women-centric card in Southeast Asia, offering industry-leading rewards for women as they spend and save with the Bank. In 2020, UOB also introduced the first savings account designed for women, the Lady’s Savings Account. Together, this product suite provides innovative features like the ability to select preferred rewards category(ies) every quarter with the Lady’s Card, and insurance coverage of up to S$200,000 for six female cancers with the Lady’s Savings Account. These perks are specially aligned with how women’s roles, responsibilities and needs evolve over time.

UOB continually reviews its Lady’s Card and Lady’s Savings Account offerings, staying relevant to the evolving interests of women customers over the last 35 years. Both offerings will be enhanced and further details will be revealed in the coming weeks. 

About UOB

UOB is a leading bank in Asia. Operating through its head office in Singapore and banking subsidiaries in China, Indonesia, Malaysia, Thailand and Vietnam, UOB has a global network of around 500 offices in 19 countries and territories in Asia Pacific, Europe and North America. Since its incorporation in 1935, UOB has grown organically and through a series of strategic acquisitions. Today, UOB is rated among the world’s top banks: Aa1 by Moody’s Investors Service and AA- by both S&P Global Ratings and Fitch Ratings.

For nearly nine decades, UOB has adopted a customer-centric approach to create long-term value by staying relevant through its enterprising spirit and doing right by its customers. UOB is focused on building the future of ASEAN – for the people and businesses within, and connecting with, ASEAN.

The Bank connects businesses to opportunities in the region with its unparalleled regional footprint and leverages data and insights to innovate and create personalised banking experiences and solutions catering to each customer’s unique needs and evolving preferences. UOB is also committed to help businesses forge a sustainable future, by fostering social inclusiveness, creating positive environmental impact and pursuing economic progress. UOB believes in being a responsible financial services provider and is steadfast in its support of art, social development of children and education, doing right by its communities and stakeholders.

[1] Includes spending on ticketing platforms, cinemas and attractions like theme parks

[2] Includes spending with online (e-commerce and marketplaces) and offline merchants

[3] The UOB Lady’s Solitaire Card has an annual income requirement of min. S$120,000

[4] In its fourth year, UOB ASEAN Consumer Sentiment Study 2023 was conducted from 1 to 26 June 2023 and surveyed 3,400 respondents online from Singapore, Indonesia, Malaysia, Thailand and Vietnam.

Source

Singapore Aquatics Announces HotelPlanner as Official Accommodation Partner

admin
-
0
Singapore Aquatics Announces HotelPlanner as Official Accommodation Partner

HotelPlanner’s sponsorship will also help the association’s elite athletes and provide them with added training and competition opportunities

SINGAPORE, March 7, 2024 /PRNewswire/ — HotelPlanner, a leading travel technology company and hotel booking platform, has inked a two-year deal to be the official accommodation partner of Singapore Aquatics for 2024 and 2025.

Singapore's 4x100m medley relay team featuring Quah Ting Wen (from left), Quah Jing Wen, Singapore Aquatics President Mark Chay, and Christopher Lee, President of APAC at HotelPlanner.com, alongside Levenia Sim and Letitia Sim.
Singapore’s 4x100m medley relay team featuring Quah Ting Wen (from left), Quah Jing Wen, Singapore Aquatics President Mark Chay, and Christopher Lee, President of APAC at HotelPlanner.com, alongside Levenia Sim and Letitia Sim.

The sponsorship will allow international participants taking part in aquatic competitions in Singapore to rely on HotelPlanner’s platforms to plan their accommodation and travel itinerary with ease and efficiency. In addition, aquatics athletes in Singapore will also benefit from favourable HotelPlanner accommodation rates when travelling overseas for competitions and training camps.

HotelPlanner’s President of APAC, Mr Christopher Lee said: “We are thrilled to come on board as Singapore Aquatics’ official accommodation partner. This collaboration represents our shared commitment to support the development of the sport and contribute to the success of Singapore’s aquatics athletes and officials. With exciting opportunities for both our athletes to travel and compete overseas and for Singapore to welcome international athletes for competitions here, we’re confident HotelPlanner can add value to the aquatics ecosystem.”

HotelPlanner joins OCBC Bank, TYR and 100Plus as official partners for Singapore Aquatics, in support of athletes and officials across all aquatics sports. As part of the agreement, Singapore Aquatics and HotelPlanner will work towards strengthening and growing aquatics in Singapore through outreach events as well as provide added training and competition opportunities for athletes.

Singapore Aquatics’ President, Mr Mark Chay said: “We are thrilled to welcome HotelPlanner as our official accommodation partner in what promises to be an exciting two years for aquatics in Singapore.

“This year will be a busy year for our athletes as they prepare for the Paris Olympics in July before welcoming the world’s top swimmers for the World Aquatics Swimming World Cup in October. This will be followed by a hectic 2025 as we plan training and competition opportunities to help our athletes prepare for the 2025 World Championships in Singapore and the 2025 SEA Games in Thailand.

“We also hope our partnership with HotelPlanner will allow us to both develop and bring more events to Singapore as we push towards our goal of being a regional aquatics hub and a world-class aquatic nation.”

The partnership with HotelPlanner was announced during a media day with members of the women’s 4x100m medley relay team – Quah Ting Wen, Quah Jing Wen, Letitia Sim, and Levenia Sim – who became the first Singapore relay team to qualify for the Olympics.

The Quahs and Sims clocked 4 min 00.87 sec at the Hangzhou Asian Games last year but dealt a disappointing disqualification after Ting Wen jumped 0.1 sec too early. However, they made amends at the Doha 2024 World Aquatics Championships, clocking a new national record of 4 min 2.88 sec to book their tickets to the Paris Olympics.

National Head Coach of Swimming, Mr Gary Tan said: “The relay team have put in an immense amount of hard work and dedication to qualify for the 2024 Paris Olympics, and their achievement is truly well-deserved. Our goal is to ensure that the girls not only have the best possible experience during the Olympics but also achieve outstanding results. This is a pivotal moment for our aquatics community, and we are excited and determined to build on this momentum to continue strengthening and expanding our relay team for future successes.”

The HotelPlanner sponsorship will allow the relay team to explore both training and competitive trips to help them get in tip-top shape for the Paris Games.

Ting Wen, 31, who is set to compete at her third Olympics said: “We are really excited about this incredible opportunity to represent Singapore at the Paris Olympics. We’ve worked really hard to qualify, and after the disappointing disqualification at the Asian Games, finally making the cut is just an indescribable feeling. We’ve grown so much even though we’ve been racing for only a short time. I’m excited about what we can accomplish in the coming year.”

Levenia, 17, who is the rookie on the team said: “It’s been a whirlwind five months since I made my debut for Singapore. To qualify for the Olympics with my sister is something we’ve dreamed of and to be able to live that dream in Paris is something special.”

ABOUT HOTELPLANNER

HotelPlanner is a leading travel technology company and hotel booking platform that combines proprietary artificial intelligence, and a 24/7 global gig-based reservations and customer service network. HotelPlanner is one of the world’s leading providers of individual, group and corporate travel bookings. Founded in 2003, HotelPlanner has enduring partnerships with the world’s largest online travel agencies, well-known global hotel chains, individual hotels, online wedding providers, ancillary lodging providers, corporations, sporting organizations from youth to professional, universities, and government agencies. HotelPlanner’s family of brands includes its flagship site HotelPlanner.com, its meetings & events-focused sites Meetings.com; EventConnect.com; and Venuexplorer.com.sg; Lucid Travel, which focuses on sports team travel; and its most recent acquisition Eventsquid, which focuses on corporate and association event registration. Learn more at https://hotelplanner.com/.

ABOUT SINGAPORE AQUATICS

Singapore Aquatics (SAQ) is the National Sports Association governing aquatic sports in Singapore. These include five key disciplines – diving, open water swimming, swimming, artistic swimming and water polo. As the national governing body, SAQ spearheads its vision of developing the Republic to become a leader in aquatic sports – regionally as well as globally. Closer to home, SAQ collaborates with various affiliate clubs and stakeholders, to proactively nurture a greater depth of local talent through various outreach efforts and programmes. Our vision is to become a world-class aquatics nation, with the goal of making every Singaporean a swimmer.

Source

Zjooshing Up Your Event With Sound & Lighting

admin
-
0

Hiring Sound Equipment For Your Event

For any type of event and function, high-quality audio is essential to make a memorable experience for you and your guests. Whether you’re planning for a wedding, corporate function, conferences, seminars, live performances. 

our blogging team have had great experience dealing with Sound & Lighting Hire for hiring audio equipment for their events in Sydney and has got you covered! they understand the demand of a perfect audio and sound system, so they offer various types of audio hire and PA systems for hire packages to suit all different event sizes.

They can provide the appropriate equipment to make sure your event is a success. Planning for a business seminar? Look no further than their wide range of audio hire equipment to provide professional-grade audio systems to create a successful event.

For more than 15 years, Sound & Lighting Hire has been providing top-notch services for Sydney corporate events and private functions. They specialise in short-term rentals of lighting, audio equipment, karaoke and jukeboxes, effects machines, staging, and glow furniture.

They are able to hire microphones for adding to the perfect event where high-quality sound is essential. They offer a range of corded and wireless microphone options for reliable performance and high-quality sound. Various microphone options serve distinct functions, and understanding these differences is crucial to ensuring your speakers and presenters have a seamless yet impactful experience. 

To learn more about the sound equipment visit their website here: https://soundandlightinghire.com.au/sound-equipment-hire/

We thought you may like to watch this very helpful video on speaker placement basics for small events and concerts.

Event Lighting Design

A Practical Guide to Stage Lighting from Focal Press is the 3rd edition by author Steven Louis Shelley. In it, he shows you step-by-step how to construct every lighting system in the Hokey light plot. Combining his diacritical analysis, drafting, and analytic use of the Slinky Method and Slinky Calculations, he presents the Periodic Table of Fundamental Lighting Systems and shows the basic methods used to create multi-instrument lighting systems.

About the author: Steven Louis Shelley has worked in theater for over 40 years as a lighting designer, production manager, and stage manager in New York City, throughout the United States, and on four continents. His lighting designs are included in the repertories of many dance companies. He’s designed lighting on and off Broadway, as well as for concerts, television, regional theater, and regional opera. Steve is also the inventor and patent holder of the award-winning Field Templates and SoftSymbols (www.fieldtemplate.com). He is a member of United Scenic Artists, Local 829.

Highlights

  • Over 100 topics, including analysis and application of the three categories of collaboration; a detailed examination of production meetings and one-on-one meetings; and meeting checklists with management and the creative team.
  • Over 50 illustrations, including Shelley’s Periodic Table of Fundamental Lighting Systems; ground plans, sections, and front elevations that illustrate basic system wash configurations for each direction of light.
  • Analysis, calculation, and step-by-step technical construction of each lighting system in the Hokey light plot.
  • Explanation of a manufacturer’s cut sheet, and how to apply basic formulas to determine the beam size, foot-candles, and gel transmission for lighting instruments.
  • Updated process of pre-programming computer lighting consoles prior to the load-in.
  • Comprehensive overview of archiving paperwork and soft copy for a production.

.

Chapters

  • Chapter 1: A Review
  • Chapter 2: Paperwork Overview
  • Chapter 3: Background Preparations and Preliminary Design Paperwork
  • Chapter 4: The Parameters
  • Chapter 5: Create the Preliminary Drawings
  • Chapter 6: Creating the Preliminary Lighting Section and Light Plot
  • Chapter 7: Compiling and Sending Out the Shop Order
  • Chapter 8: Cuts and Changes
  • Chapter 9: The Light Plot, Section, and Support Paperwork Packet
  • Chapter 10: The Load-In and Focus Packet
  • Chapter 11: The Cue Construction Packet
  • Chapter 12: Prior to the Load-In
  • Chapter 13: The Load-In and Setup
  • Chapter 14: The Focus Session
  • Chapter 15: The Light Cue Level Setting Session and Technical Rehearsals
  • Chapter 16: The Performance
  • Chapter 17: Archiving and Final Activities

Buy the Design With Lighting book here: Biblio – Design With Light

If you are looking to hire Sound and Lighting equipment in Sydney, visit the blogging team recommended Sydney Sound and Lighting Hire company’s website here: https://soundandlightinghire.com.au/

Luye Pharma’s Innovative Drug Zepzelca® (Lurbinectedin) Launched in Hong Kong and Macao

admin
-
0
Luye Pharma’s Innovative Drug Zepzelca® (Lurbinectedin) Launched in Hong Kong and Macao

Reshaping the landscape for the second-line treatments of Small Cell Lung Cancer

HONG KONG and MACAO, March 7, 2024 /PRNewswire/ — A symposium called the New Treatment Paradigm for Small Cell Lung Cancer (SCLC) organized by the Hong Kong Cancer Therapy Society (HKCTS) with support from Luye Pharma Group (Luye Pharma) took place in Hong Kong yesterday. At the conference, Luye Pharma announced the launch of its innovative drug Zepzelca® (lurbinectedin) for the treatment of SCLC in both Hong Kong and Macao, the two Special Administrative Regions of China.

The launch ceremony of Zepzelca®(lurbinectedin)
The launch ceremony of Zepzelca®(lurbinectedin)

Lurbinectedin is a new chemical entity with a novel mechanism of action. It was approved for launch in Macao in November 2023 and in Hong Kong in December 2023 for the treatment of adult patients with metastatic SCLC with disease progression on or after platinum-based chemotherapy. The drug was also approved by the U.S. Food and Drug Administration (FDA) through the accelerated approval process in 2020. For 27 years, it has been the only new chemical entity approved by the U.S. FDA for the treatment of relapsed SCLC since 1997.

Lurbinectedin has overcome a bottleneck in the second-line treatments of SCLC 

SCLC is one of the most aggressive lung cancers, with a five-year survival rate of only 7%[1]. Most patients would experience a relapse or develop drug resistance after the initial treatment, with an mOS (median Overall Survival) of only 4 to 5 months after receiving further chemotherapy[2].

“SCLC is one of the most malignant and highly recurrent subtypes of lung cancer, and for over 20 years, there has been no substantial progress in developing second-line treatments for the disease after a relapse and in improving patient survival,” said Dr. Herbert Loong, an Associate Professor from the Department of Clinical Oncology at the Chinese University of Hong Kong and a council member of HKCTS, who chaired the symposium. “Different from traditional chemotherapy, lurbinectedin is a selective inhibitor of oncogenic transcription with notable activity in SCLC. We believe it can become a new standard second-line treatment for SCLC and help improve patient survival.”

Promising results for Chinese patients in a clinical study

The approval of lurbinectedin in countries and regions including the U.S., Hong Kong and Macao is mainly based on an open-label, multicenter and single-arm study (a Phase 2 basket trial) in 105 adult patients with SCLC (including both platinum-sensitive and platinum-resistant patients) who experienced disease progression after receiving platinum-based chemotherapy. In this trial, they were treated with lurbinectedin alone by receiving 1-hour intravenous infusion of the drug every 3 weeks at a dose of 3.2mg/m2. The study was published in The Lancet Oncology[3]. It demonstrated an ORR (Overall Response Rate) of 35.2%, an mDoR (median Duration of Response) of 5.3 months, and an mOS of 9.3 months for all patients treated with lurbinectedin[3].

“Lurbinectedin was found to be superior to current standard treatments based on their historical data in terms of anticancer activity and safety, and it was effective in both platinum-sensitive and platinum-resistant SCLC patients,” said Dr. Antonio Calles, a specialist from the Department of Medical Oncology at Hospital General Universitario Gregorio Marañón in Madrid, Spain. “In addition to being used as a monotherapy, lurbinectedin is also expected to be used in combination with chemotherapy, immunotherapy or other therapies, to allow SCLC patients to benefit more from it.”

A single-arm, Phase 1 clinical study with dose escalation and expansion for lurbinectedin was conducted, to evaluate its safety, tolerability, pharmacokinetics (PK) and preliminary efficacy in Chinese patients with advanced solid tumors, including recurrent SCLC. The study showed an ORR of 45.5%, an mDoR of 4.2 months, and an mOS of 11.0 months for SCLC patients treated with lurbinectedin (at the FDA-approved dose of 3.2 mg/m2 via 1-hour intravenous infusion every 3 weeks).

At the symposium, Professor Sheng Ye, Director of Clinical Oncology at the First Hospital of Sun Yat-sen University, said: “This study was designed to evaluate the preliminary efficacy and safety of lurbinectedin in Chinese patients. We are excited to see that the performance of lurbinectedin at the FDA-approved dose in Chinese patients with relapsed SCLC whose condition has progressed after receiving a first-line platinum-based chemotherapy is comparable to or even better than its performance in the SCLC cohort of an overseas Phase 2 basket trial in terms of efficacy and patient survival. Lurbinectedin is expected to become a new treatment option of value for Chinese SCLC patients.”

Helping to make innovative drugs more accessible for patients

To date, lurbinectedin has been approved for launch in 16 countries and regions worldwide. Luye Pharma has been granted the rights to develop and commercialize lurbinectedin in Chinese mainland, Hong Kong, and Macao, to allow Chinese patients to benefit from the innovative therapy as soon as possible. In addition to being approved for launch in Hong Kong and Macao, the drug is also under review for its New Drug Application (NDA) in Chinese mainland with a priority review designation.

Andy Siow, APAC VP of Luye Pharma (International), said: “After more than two decades, there is finally a significant advancement in addressing the relapsed SCLC, offering patients the long-awaited hope and clinically improved outcomes. With the introduction of Zepzelca in Hong Kong and Macao, we are actively collaborating with various stakeholders to enhance its accessibility to all patients. Our objective is to expedite patient access to the medication, enhancing their survival prospects and alleviating treatment burdens.“

About Zepzelca®(lurbinectedin)

Zepzelca (lurbinectedin) is an analog of the marine compound ET-736 isolated from sea squirt Ecteinascidia turbinata in which a hydrogen atom has been replaced by a methoxy group. It is a selective inhibitor of the oncogenic transcription programs on which many tumors are particularly dependent. Together with its effect on cancer cells, lurbinectedin also presents a marked effect on tumor microenvironment by inhibiting transcription and secretion of selected cytokines by tumor-associated macrophages.

Lurbinectedin has been recommended by multiple clinical guidelines. For instance, it has been recommended as a preferred option in subsequent systemic treatment for SCLC patients with a chemotherapy-free interval (CTFI)≤6 months by the NCCN Clinical Practice Guidelines in Oncology for Small Cell Lung Cancer (2024.V2)[4], and has been also recommended for the treatment of relapsed SCLC by the Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up[5] (published in 2021) and the CSCO Guidelines for the Diagnosis and Treatment of Small Cell Lung Cancer 2023 [2].

About Luye Pharma Group

Luye Pharma Group is an international pharmaceutical company dedicated to the R&D, manufacturing and sale of innovative medications. The company has established R&D centers in China, the U.S. and Europe, with a robust pipeline of over 30 drug candidates in China and more than 10 drug candidates in other international markets. Luye Pharma maintains high-level international standards in novel drug delivery technologies including microspheres, liposomes, and transdermal drug delivery systems. The company has also achieved multiple innovations in new chemical entities and antibodies, and is actively making strategic developments in the fields of cell therapies and gene therapies.

Luye Pharma is developing a global supply chain of 8 manufacturing sites built up around the world, with GMP quality management and control systems established in line with international standards. With more than 30 products covering the central nervous system, oncology, cardiovascular, metabolism and other therapeutic areas, business is conducted in over 80 countries and regions around the world, including the largest pharmaceutical markets – China, the U.S., Europe and Japan, as well as in fast growing emerging markets.

Source

The first over-the-counter continuous glucose monitor just got cleared by the FDA. Here’s what it does — and why monitors like these are popular with nondiabetics too.

admin
-
0
The first over-the-counter continuous glucose monitor just got cleared by the FDA. Here’s what it does — and why monitors like these are popular with nondiabetics too.
A young man outdoors stretching his leg on a bench wears a continuous glucose monitor on his upper arm.

What you need to know about continuous glucose monitors following the FDA’s approval of the first over-the-counter device. (Getty Images)

Continuous glucose monitors (CGM) are about to become more accessible, as the Food and Drug Administration announced clearing the first over-the-counter device on March 5. The Dexcom Stelo Glucose Biosensor System will be available this summer and is intended for anyone 18 years and older who does not use insulin. This would include individuals with diabetes using oral medications to treat their condition, as well as people without diabetes who are looking to better understand how diet and exercise may impact blood sugar levels, according to the FDA’s statement. The agency does note that the nonprescription CGM should not be used by people with “problematic hypoglycemia,” also known as low blood sugar, “as the system is not designed to alert the user to this potentially dangerous condition.”

Given the increased access to these monitors and the growing trend of people who don’t have diabetes using them as “personal health devices” to monitor how foods impact their blood sugar levels and to motivate themselves to make healthy behavioral changes, it’s important to understand what a CGM is and who really needs one. Here’s everything you need to know.

🩸 What is a continuous glucose monitor?

It’s a wearable technology that allows you to track blood sugar levels 24 hours a day, without having to prick your finger for a blood test. The device is worn on either the arm or the abdomen, where a small sensor is inserted just under the skin. The sensor measures glucose levels and wirelessly transmits the data to a device, via a downloadable app, for viewing.

🔬 What information does it provide?

CGMs provide continuous information on glucose levels, allowing a user to see what their current numbers are at any moment, while also getting insight into trends, such as foods, physical activities, stressors or illnesses that may cause a spike. The alternative is using a finger-stick blood test, which provides data for only a point in time. “You don’t know if that number is going up or going down or holding steady,” Dr. Michael Natter, an endocrinologist at NYU Langone Health and a type 1 diabetic, tells Yahoo Life. The goal is to keep blood sugars within a certain range, as levels too high or too low can damage organs and lead to potentially life-threatening complications. For diabetics, this often requires management through insulin therapy.

🤷‍♀️ Who needs to use a CGM?

These devices are made primarily for those living with type 1 or type 2 diabetes who are managing their condition with insulin. However, Dexcom reports that there are approximately 25 million people in the U.S. living with type 2 diabetes who do not use insulin and can still benefit from CGM technology.

ADVERTISEMENT

Advertisement

According to Cleveland Clinic, the wearable device can provide several benefits, such as:

  • Showing a more complete picture of how blood sugar levels change over time.

  • Pinpointing any patterns in blood sugar changes so physicians can create a personalized plan for patients.

  • Warning about blood sugar that is too high or too low.

  • Reducing the number of finger-stick tests patients need to do, although they may still be required for diabetes management.

Natter points out that there’s also a population of diabetics who haven’t had access to a CGM because of different scenarios where insurance is unwilling to cover the cost of the device. Although the price of the over-the-counter device isn’t yet available, he says that population would “benefit from access to affordable nonprescription” CGMs.

💪 Why would a nondiabetic use it?

These monitors are the latest tool in biohacking — the trending practice of using medical methods to boost physical or mental performance, enhance health and well-being, or reach specific health goals. And while they’ve gained popularity among certain fitness fanatics and wellness gurus, experts have tried to figure out why.

ADVERTISEMENT

Advertisement

Dr. Robert Shmerling of Harvard Health identified some possible reasons, such as potentially identifying prediabetes, “optimizing” blood sugar for “peak mental or physical performance,” the “illusion” of feeling more in control of their health, and simple curiosity.

However, there’s little research published to solidify any potential benefits of wearing a CGM as a nondiabetic. Some experts, including Natter, are skeptical. “I think there are downsides to having too much data. Because while these continuous glucose monitors are wonderful and relatively accurate, they are not meant to pick up very subtle glucose swings. And when we see a small spike after a meal, that could actually be very normal,” he says. “I fear that might be overinterpreted and misread as pathologic or bad.” Natter says that he’s also wary of foods becoming “demonized” because of resulting blood sugar spikes.

🤔 The main takeaway

While Dr. Jeff Shuren, director of the FDA’s Center for Devices and Radiological Health, tells Yahoo Life that “giving more individuals valuable information about their health, regardless of their access to a doctor or health insurance, is an important step forward in advancing health equity for U.S. patients,” some physicians are hesitant about individuals monitoring their medical data on a nonprescription device.

“It gets a little bit nuanced,” says Natter. “If there’s someone taking medication and monitoring with any device, I think it’s safest to have a medical professional shepherding that patient through.”

Source

WEPACK 2024 will present much-expected kaleidoscopic highlights this April

admin
-
0
WEPACK 2024 will present much-expected kaleidoscopic highlights this April

SHENZHEN, China, March 7, 2024 /PRNewswire/ — As part and parcel of the industrial manufacturing industry, the packaging industry is accelerating transformation and development, with continuous emergence of relevant new industries, business formats, technologies and models bringing new opportunities for further cross-border integration, industrial chain ecologization, and automated intelligence development in the industry.

WEPACK 2024 will be held from April.10-12 at the Shenzhen World Exhibition & Convention Center (Bao'an New Hall), China
WEPACK 2024 will be held from April.10-12 at the Shenzhen World Exhibition & Convention Center (Bao’an New Hall), China

Based on excellent specialization, marketization and internationalization, WEPACK organized by RX has already become an international window for cutting-edge information exchange in the global packaging industry and provided the Chinese packaging industry with a platform to link to the world and showcase its strength over the years.

To be held at Shenzhen World Exhibition & Convention Center from April 10 to 12, 2024, WEPACK 2024 will feature six concurrent shows, including: SinoCorrugated South 2024, SinoFoldingCarton 2024, PACKCON 2024, DPrint 2024, SinoPaper South 2024, and Food Pack & Tech 2024. It will compose the charm of the packaging industry in a new posture, create a carrier-class grand show in the international packaging industry characterized by a larger scale, higher influence, wider coverage and richer exhibit categories, and pool together 1,200+ exhibitors, with an estimate of 100,000+ global packaging industry personnel attracted to the venue.

•    120,000 m2 of exhibition area
•    50,000+ cardboard and carton manufacturing enterprises
•    30,000+ folding carton color printing manufacturing enterprises
•    10,000+ label and flexible packaging manufacturing enterprises
•    1,000+ graphic express printing enterprises
•    20,000+ packaging R&D and purchasing personnel of brand owners
•    1,000+ raw paper distributors
•    3,000+ food & catering packaging enterprises
•    6,000+ overseas paper packaging enterprises (from 110 countries and regions)
•    3,000+ representatives from overseas regions
•    50+ hot trend forums + events of the packaging industry

WEPACK 2024 floor plan at the Shenzhen World Exhibition & Convention Center (Bao'an New Hall)
WEPACK 2024 floor plan at the Shenzhen World Exhibition & Convention Center (Bao’an New Hall)

Six concurrent exhibitions, build a collaborative development pattern across the whole packaging industrial chain
No success could be achieved in a single field without considering the bigger picture. In the current era, the economic development blueprint of “the industrial chain as a whole” is being sketched out. A key driver of the packaging industry’s high-quality development, WEPACK 2024, based on over twenty years of industry accumulation, moves faster to integrate into the global packaging industrial chain. With an exhibition area of 120,000 m2, this edition has incorporated 6 major sectors of packaging series exhibitions. By that time, carton processing equipment and materials, folding carton processing equipment and materials, digital label printing equipment and materials, packaging container manufacturers, raw paper manufacturers, and catering packaging processing equipment enterprises and material suppliers will jointly manifest the new high ground of packaging intelligent manufacturing.

  • SinoCorrugated South 2024
    SinoCorrugated South is not only a “grand stage” for carton manufacturing, but also an irreplaceable trading and exchange platform in the global carton industry. Outstanding exhibitors from various segments will come in droves to SinoCorrugated South 2024, showcasing their star products and delivering rich, diverse, and cutting-edge corrugated box processing solutions to the industry.
  • SinoFoldingCarton 2024
    A specialized exhibition for folding carton printing and post-press processing equipment, consumables, technologies, and services, SinoFoldingCarton 2024 pools more than 400 renowned brands from home and abroad. Exhibiting over 500 high-end and cost-effective devices, and more than a thousand types of consumables under one roof, it serves as a preferred platform for purchasing folding carton processing equipment and gaining information about new industry trends.
  • DPrint 2024
    Focused on digital application equipment and technologies of whole-category packaging products printing and forming, DPrint 2024 is the only exhibition in China that spotlights digital printing solutions in the packaging industry. Previous editions of the exhibition pooled together hundreds of well-known supplier brands from home and abroad to showcase currently advanced printing and forming digital application technologies for labels, cartons, folding cartons, flexible packaging, metals, etc. together, as well as high-end and cost-effective equipment and consumables, so as to drive the development and application of digital printing technologies. 
  • SinoPaper South 2024
    SinoPaper South 2024 will comprehensively demonstrate three major categories: packaging paper, commercial printing paper, and special paper, and pool resources from numerous overseas paper mills, so as to enrich raw paper purchase channels for enterprises with paper demands and lower production costs. The “raw paper trade purchase zone” to be set up at the exhibition will provide more quality raw paper purchase options for paper packaging enterprises in the Greater Bay Area of South China.
  • Food PACK & TECH 2024
    Specializing in the food contactable packaging field, FOOD PACK & TECH 2024 covers the whole process of manufacturing, processing, forming and detection, etc. for finished packaging products. Committed to creating uniqueness and concreteness within the packaging industry, it serves as a one-stop specialized trade platform showcasing leading food packaging product processing equipment and technologies, as well as food-grade packaging materials.
  • PACKCON 2024
    Jointly organised by the China Packaging Federation and RX, PACKCON is a platform for sourcing and exchanging all types of packaging and containers, combining on-site exhibitions, conferences, events, live courses, business matching and other professional services, and bringing together more than 30,000 packaging purchasing decision makers from the eight end-user fields, and it is the perfect platform for packaging and containers suppliers to learn about the market information, get high-quality orders, and build up business contacts.

With increasing internationalization, global industry associations, agencies, and trade visitors convene in Shenzhen

Based on its ongoing dive in the domestic packaging industry, the organizer RX actively grasps overseas incremental markets, taps into emerging market regions, pools global purchase power, and assists suppliers of equipment and consumables in the packaging industry in expanding global trade, precisely opening up dual tracks of both domestic and overseas markets, and achieving dual value added in branding and profits.

Domestically, an estimate of 50,000+ cardboard and carton manufacturing enterprises, 30,000+ folding carton and color printing manufacturing enterprises, 10,000+ label and flexible packaging manufacturing enterprises, and 20,000+ packaging R&D and purchasing personnel of brand owners will visit the site.

Internationally, RX possesses 600,000 carton enterprise databases at home and abroad covering foreign and domestic target customers. They are upgraded in a timely manner to strictly ensure up-to-date data. Trade buyers and regional agencies will be selected from such databases for onsite visit and consultation.

It is foreseeable that packaging industrial chain enterprises at home and abroad will gather in Shenzhen from April 10 to 12, joining hands to draw the blueprint for the global packaging industry development.

50+ concurrent events bring together global packaging industry big shots, with excitements staged one after another

Apart from a complete array of exhibits in the packaging industry chain, the exhibition will concurrently host a series of high-standard forums, and invite representatives from domestic and international packaging industry associations, authoritative institutions, renowned enterprises in the industry, and industry leaders to the site. These forums will focus on hot topics of common interest in the packaging industry to unfold substantiated academic feasts and brainstorms one after another, where continuous excitements will maximize the experience feeling of both exhibitors and visitors.

In the past 20-odd years, the organizer of WEPACK, along with domestic and international packaging enterprises, associations, institutions, media, and numerous personnel who care about the industry’s development, experienced the transformation era in the packaging industry together, and witnessed and accomplished today’s new landscape in the packaging industry. In the future, WEPACK will maintain an open, collaborative, and innovative stance, assume the task of driving packaging industry development, grow and progress together with the industry, jointly build a grand platform for market development, and usher in a new era for the global packaging industry!

April 10th-12th let’s meet at the Shenzhen World Exhibition & Convention Center (Bao’an New Hall)!

CONTACT: Oliver Zhang, oliver.zhang@rxglobal.com

Source: RX (China) Investment Co., Ltd.

Source

Newborn Town Gains YoY Increase of over 280% in Profit Attributable to Owners as MENA Market and New Products Become Key Growth Drivers

admin
-
0
Newborn Town Gains YoY Increase of over 280% in Profit Attributable to Owners as MENA Market and New Products Become Key Growth Drivers

HONG KONG, March 6, 2024 /PRNewswire/ — Newborn Town Inc. (“Newborn Town”; 9911. HK) released its positive profit alert for the year ended 31 December on 5 March. The company has continued its growth momentum and achieved a remarkable increase in major indicators.

Newborn Town’s total revenue for 2023 is expected to be approximately RMB3,270 million to RMB3,410 million, representing a YoY increase of 17% to 22%. The net profit will see a YoY rise of 161% to 182%, as it’s expected to be around RMB750 million to RMB810 million.

The profit attributable to the owners of Newborn Town will reach RMB500 million to RMB560 million, increasing by 285% to 331%. The adjusted EBITDA will be around RMB670 million to RMB730 million, representing an increase of around 79% to 95% compared to the corresponding period in 2022.

Newborn Town is the tech company that eyes global social networking and entertainment markets
Newborn Town is the tech company that eyes global social networking and entertainment markets

According to the announcement, Newborn Town’s profit growth has been achieved due to the progress made in the social networking business, especially in MENA and new social apps.

The past year has witnessed continued rapid breakthroughs in major markets like MENA and remarkable progress in the scale-up and commercialization of ‘second-mover’ apps like SUGO and TopTop, enhancing Newborn Town’s overall businesses’ high-quality growth.

MICO, YoHo, SUGO and TopTop, the flagship apps under Newborn Town’s ‘pan-audience social networking business’, aim to meet global users’ diversified social demands.

Most social apps in this segment have made rapid strides as they’ve evolved into top-notch platforms in emerging markets like MENA and SEA.

Based on the localized capabilities accumulated in the long-term process of globalization, Newborn Town has fully implemented the ‘replication’ strategy, enhancing the rapid scale-up of new products in target markets while lowering operational costs and upgrading commercialization efficiency.

For example, the companion-based social app SUGO showed a surge in revenue and profit in 2023, representing a triple YoY increase. Besides, it has been ranked among the top 30 Chinese non-game publishers in terms of overseas revenue released by data.ai many times.

Newborn Town has also accelerated its exploration of the ‘diverse-audience social networking business’ and gained ground. In 2023, the company completed the acquisition of BlueCity and achieved profitability.

On 1 January 2024, Newborn Town officially unveiled the online community app HeeSay to over 70 countries and regions worldwide. Based on the user base and brand influence that the international version of Blued has accumulated previously, HeeSay has revved up its global business layouts with the advantages of deep localization.

It’s noteworthy that HeeSay has achieved sustained profitability since its closed beta test. Henceforth, the boundary of Newborn Town’s social networking business won a further expansion while its commercialization efficiency got continuous upgrades.

Apart from the above-mentioned segment, Newborn Town’s innovative business has achieved breakthroughs in 2023. The flagship game, Alice’s Dream: Merge Island, witnessed a continued rise in monthly revenue, reaching over 8 million US dollars in the fourth quarter of 2023.

Besides, Alice’s Dream was also a top-ranked frequenter in Sensor Tower’s lists regarding overseas revenue and downloads this year.

In addition to the success of Alice’s Dream, Newborn Town rolled out new apps like Taylor’s Secret, Merge Cove, and Sudoku to capture a larger global market share of puzzle games.

Notably, according to data.ai, Sudoku ranked third on the US mid-core casual games list for June 2023.

In 2023, Newborn Town took the ‘pan-audience social networking business’ as its core segment and achieved further breakthroughs among key markets while verifying the growth potential of newly launched products.

Meanwhile, the diverse-audience social networking business and the game-centric innovative business have progressed smoothly, jointly promoting the high-quality growth of Newborn Town.

Newborn Town will continue to increase its input and dig deep into vast opportunities in MENA while focusing on diverse-audience social networking and quality games to gain diversified and sustainable growth in the years to come.

It’s reported that Newborn Town will hold the annual results announcement in Hong Kong on March 22, 2024.

Source

Innovative Visionary Mark W. Womack Strengthens Bridgewest Perth Pharma Pty Ltd Board, Amplifying NovaCina’s Growth Vision

admin
-
0
Innovative Visionary Mark W. Womack Strengthens Bridgewest Perth Pharma Pty Ltd Board, Amplifying NovaCina’s Growth Vision

Mark W. Womack Named to Bridgewest Perth Pharma Pty Ltd Board of Directors

MIAMI and PERTH, Australia, March 6, 2024 /PRNewswire/ — Bridgewest Perth Pharma, a global pharmaceutical supply and manufacturing company, with subsidiaries NovaCina and LumaCina, announced today the appointment of Mark W. Womack as a Director of the Board.

Mark W. Womack Named to Bridgewest Perth Pharma Pty Ltd Board of Directors
Mark W. Womack Named to Bridgewest Perth Pharma Pty Ltd Board of Directors

“We are thrilled to have Mark join the Board, as a Director of the Company,” said Dr. Masood Tayebi, Co-Founder and Chief Executive Officer of Bridgewest Group. “Mark has demonstrated his skills as both an entrepreneur and a visionary with multiple highly successful organizations, and we are excited to have his advice and wisdom at the Board level for Bridgewest Perth Pharma broadly, and more specifically NovaCina’s commercial manufacturing of sterile injectables.”

Mark currently serves as CEO of BioCina, a Bridgewest Group funded CDMO providing end-to-end biologics solutions for microbial, pDNA and mRNA modalities globally. Prior to BioCina, as CEO of KBI Biopharma and Selexis SA, he spearheaded a run rate of over 30% YOY revenue increase in only 6 months and implemented a new commercial strategy to generate significantly greater client program size and profitability. As CEO and Managing Director of Stelis Biopharma, Mark ushered efforts to build and qualify a state-of-the-art vaccine facility in record time.

As the CBO for AGC Biologics, one of the world’s leading global biopharma CDMO’s, Mark led the organization to achieve nearly a 300% increase in new sales in just two years. Over two years, he drove the acquisition of many of the top large pharma companies into the AGC Biologics Client portfolio.

Prior to joining AGC Biologics, Mark served over 20 years as a management consulting industry leader and C-level client advisor, guiding many of the world’s renowned companies to achieve record highs in revenue and profit. He served as a Principal with Capgemini, an EVP with Celerant Consulting and as COO of two other international consultancies. While at Capgemini, he led a $20B post-merger integration within General Motors.

“This is a tremendous opportunity to help guide and shape the future of the NovaCina and LumaCina organizations. I’m inspired by the vision we share and excited about the journey we will travel to realize it,” said Mark W. Womack.

In April 2023, Bridgewest Group announced the acquisition of the Pfizer Perth cGMP sterile injectable manufacturing plant, and the formation of Bridgewest Perth Pharma, including the NovaCina CDMO division and LumaCina pharmaceutical supply division. NovaCina has a preeminent history. The site has produced more than 600 injectable products with distribution to nearly a hundred countries globally, and has an excellent track record spanning all major regulatory approvals including US FDA, TGA, and European regulatory agencies.  Since the acquisition, the company has invested significantly into both NovaCina and LumaCina. It has grown NovaCina’s manufacturing capabilities to include Pre-filled Syringes (PFS) and has expanded LumaCina’s product catalog, growing its commercial reach into several new global markets.

About Bridgewest Perth Pharma
Bridgewest Perth Pharma is a global pharmaceutical company, wholly owned by private investment firm Bridgewest Group. It operates through its two divisions, NovaCina, the company’s CDMO, and LumaCina, the company’s pharmaceutical marketing and supply division. Bridgewest Perth Pharma brings together innovative life sciences and talented people to meet the escalating demand for high quality drug manufacturing and therapeutics. For more information, visit: https://bridgewestperthpharma.com.au/

Media Contact: Jenny Bourbiel, jbourbiel@bridgewestgroup.com

Source

1...476477478...487Page 477 of 487

EDITOR PICKS

POPULAR POSTS

POPULAR CATEGORY

ABOUT US

Blogchicks is your lifestyle news, entertainment, travel, music, health & fashion website. We provide you with the latest breaking news and videos, something for everyone.

Contact us: info@blogchicks.com.au

FOLLOW US

© Blog Chicks 2024